Sipos, M.; Farcas, A.; Leucuta, D.C.; Bucsa, C.; Huruba, M.; Mogosan, C.
Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals 2021, 14, 441.
https://doi.org/10.3390/ph14050441
AMA Style
Sipos M, Farcas A, Leucuta DC, Bucsa C, Huruba M, Mogosan C.
Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals. 2021; 14(5):441.
https://doi.org/10.3390/ph14050441
Chicago/Turabian Style
Sipos, Mariana, Andreea Farcas, Daniel Corneliu Leucuta, Camelia Bucsa, Madalina Huruba, and Cristina Mogosan.
2021. "Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly" Pharmaceuticals 14, no. 5: 441.
https://doi.org/10.3390/ph14050441
APA Style
Sipos, M., Farcas, A., Leucuta, D. C., Bucsa, C., Huruba, M., & Mogosan, C.
(2021). Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals, 14(5), 441.
https://doi.org/10.3390/ph14050441